Loading clinical trials...
Loading clinical trials...
Additional Hyperbaric Oxygen After Lower Extremity Amputation - A Randomized Controlled Trial
This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.
Hyperbaric oxygen therapy has been used to treat hard to heal wounds for decades. Amputation, especially distal lower extremity amputations have the same problem with healing and patients often need to be re-amputated more proximally. In these patients oxygen levels are often the decisive factor. Providing additional oxygen under hyperbaric conditions will increase tissue oxygen concentration sufficient for the amputation stump to heal. This will give the patients a more distal amputation with better condition for ambulation.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Diakonhjemmet Hospital
Oslo, Norway
Orthopedic Center, Ullevål University Hopspital
Oslo, Norway
Start Date
July 4, 2018
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2026
Last Updated
March 30, 2025
120
ESTIMATED participants
Hyperbaric oxygen therapy
PROCEDURE
Lead Sponsor
Oslo University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07480161